top of page
shutterstock_1150075523.jpg

Investor Relations, Built by Biotech Operators

Kendall IR provides senior-level strategic and operational investor relations to biotech and life sciences companies. We are former industry executives who have sat in the operating seats our clients occupy today, with careers spanning research and development, program leadership, corporate strategy, and in-house investor relations at both clinical-stage and commercial companies.

 

That background shapes how we work. We understand the science behind your programs, internal company dynamics, the questions investors will ask, and that disclosure decisions carry real consequences. We translate complex clinical and regulatory narratives into a clear, credible equity story.

 

We work as an extension of your team, not a vendor at arm's length, serving as a strategic thought partner unafraid to offer alternative or more provocative perspectives. Whether you are preparing for an IPO, communicating a pivotal data readout, or building an IR function from the ground up, we bring the judgment of people who have done this work from the inside.

shutterstock_2700519185.jpg

What We Do

We support the full arc of investor communications for private and public biotech companies. Our engagements range from ongoing IR counsel to focused, event-driven support around financings, data disclosures, and corporate milestones. Every program is built around your specific catalysts, your investor audience, and the way healthcare specialists actually evaluate risk and value.

5. Strategic Plan.png

Strategic Planning & IR Program Design

We define your investor communication goals and how to best achieve them

Complimentary
Assessment

Contact us to set up a free assessment of your company.

6. Message Development.png

Message Development & Investment Thesis

We work with you to craft your corporate story

7. Material Preparation.png

Materials Preparation

We create compelling press releases, corporate slide decks and Q&A documents that will engage the investment community

8. External Representation.png

External Representation

We are available to present your message at investor meetings and events

10. Investor Events.png

Investor Events & Conferences

We plan and execute conference calls, investor days and other key investor events

3. Execute.png

Financing & Capital Markets Communications

We support the investor-facing side of the full financing lifecycle

1. Knowledge.png

Special Situations

Some moments carry outsized weight: a pivotal data readout, an FDA decision, a partnership, a leadership transition, or an unexpected challenge.

9. Investor & Sell-side Targeting.png

Investor & Sell-side Targeting

We make sure the right people are hearing your message

asset-generation-462fe9a0-3d6d-45d1-aa13-42c06e008b37-1.png

WHY KENDALL IR?

Unlike many IR and communications consultants, we come from inside biotech. Our team has led programs, worked through clinical and regulatory milestones, and served as in-house investor relations officers. We know what a data readout looks like from the operating side, how boards think about disclosure, and how specialist investors separate signal from noise.

 

That perspective, combined with senior-level attention on every engagement, is what we offer. We take on a focused set of clients so that experienced people, not junior staff, do the work. When you engage Kendall IR, you get partners who understand your science and treat your story with the care it deserves.

bottom of page